Volume 32, Issue 155 (November & December 2024)                   J Adv Med Biomed Res 2024, 32(155): 477-488 | Back to browse issues page

Ethics code: IR.ZUMS.REC.1400.030

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shamsi S, Mahdei Nasirmahalleh N, Shirmohammadpour M, Afshar D, Mirzaei B. Design, Cloning, and Expression of PLC-Darpin Fusion Protein as Putative Immunotoxin in a Prokaryotic Host. J Adv Med Biomed Res 2024; 32 (155) :477-488
URL: http://journal.zums.ac.ir/article-1-7563-en.html
1- Department of Microbiology and Virology, Zanjan University of Medical Sciences, Zanjan, Iran
2- Student Research Committee, Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran 3Student Research Committee, Department of Medical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
3- Department of Microbiology and Virology, Zanjan University of Medical Sciences, Zanjan, Iran , dr.bahman.m@gmail.com
Abstract:   (38 Views)
Background & Objective:  Cancers are common genetic disease that can cause death. Bacteria, such as Clostridium novyi, potentially could be used in cancer treatment by producing an enzyme called phospholipase C (PLC), which causes cell lysis. The aims of this study are to cloning and expression of PLC- Darpin in prokaryotic host.
 Materials & Methods:  Briefly, the PLC- Darpin gene sequence was amplified using PCR. The amplified fragment was conducted into the pET28a vector, transformed into E. coli BL21 (DE3), and screened by the double digestion method. Protein expression was analyzed using SDS-PAGE and checked with specific antibodies using the western blotting method. The cloned fragment was confirmed using the PCR colony method.
Results:  Designed PLC- Darpin protein sequence (1600 bp) was successfully amplified by specific primers taking advantage of PCR method. Then, cloned PLC- Darpin candidate sequence was reconfirmed by digestion procedure, and colony PCR. Finally, 60 KDa expressed protein in prokaryotic host reconfirmed by SDS- page and western blotting.
Conclusion:  Fused PLC enzyme to Darpin protein could be considered as a main putative immunotoxin due to its enzymatic role and cytotoxicity which may be utilized as a therapeutic choice in the future with further investigations.
 
Full-Text [PDF 1038 kb]   (27 Downloads)    
Type of Study: Original Article | Subject: Life science
Received: 2024/09/8 | Accepted: 2025/02/13 | Published: 2024/10/10

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb